Pfizer Shares Gain Amid Reports of Deal with the US Government
-
最新报道：Pfizer shares rose 3.30% to $24.64 following reports of a potential drug-pricing agreement with the Trump administration under the "Most Favored Nation" initiative, which would see the company voluntarily sell medications through Medicaid at reduced prices aligned with those paid by wealthier nations. The deal comes amid White House pressure to lower drug costs, with the administration's September 29 deadline for voluntary commitments. Pfizer's stock has faced long-term declines, down 8.90% over the past year, but analysts project a $28.90 price target, suggesting 17% upside from current levels.
下一篇
Trump’s CBD Pivot: Which Cannabis Stocks Could Win Big?
- President Trump's recent endorsement of hemp-derived CBD has boosted marijuana stocks, wit...
24小时热点
热点专题
407106